Table 2.
Baseline characteristics of patients admitted with acute ischemic stroke during the COVID-19 era.
| COVID testing not performed | COVID (-) | COVID (+) | |
|---|---|---|---|
| Hospital admission for AIS and TIA, n | 125 | 121 | 9 |
| Age, median (IQR) | 73 (63–81) | 72 (60–84) | 73 (61–80) |
| Male, n (%) | 56.80% | 47.90% | 77.80% |
| BMI | 26 (24–30) | 27 (24–31) | 26 (23–28) |
| Coronary Artery Disease | 10.40% | 19.80% | 44.40% |
| Diabetes | 34.40% | 25.60% | 44.40% |
| Hypertension | 79.20% | 71.90% | 66.70% |
| Atrial Fibrillation | 17.60% | 28.90% | 0.00% |
| Dyslipidemia | 53.60% | 48.80% | 66.70% |
| AIS and TIA, n | 125 | 121 | 9 |
| NIHSS on arrival | 3 (1–7) | 8 (2–16) | 6 (1–20) |
| IV tPA, n (%) | 10 | 18 | 2 |
| MET, n (%) | 14 | 34 | 1 |
| DNT, min, median (IQR) | 48 (29–52) | 38.5 (34–48) | 94.5 (24–165) |
| DGPT, min, median (IQR) | 78.5 (44–96) | 86 (48–116) | 244 (244–244) |
| LOS, median (IQR) | 3 (2–5) | 5 (3–9) | 17 (9–46) |
AIS, Acute Ischemic Stroke; IQR, interquartile range; IV tPA, intravenous alteplase; MET, mechanical thrombectomy; DNT, door-to-needle time; DGPT, door-to-groin puncture time; NIHSS, National Institutes of Health Stroke Scale; LOS, length of stay; TIA, transient ischemic attack.